Clinical Trial Update: A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain [Phase 2]

View source ↗

Summary

Phase 2 trial updates safety and efficacy of BAY2395840 in diabetic neuropathic pain due to diabetic peripheral neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Peripheral Neuropathy
• Neuropathic Pain
• Peripheral Neuropathic Pain

Drugs mentioned

• BAY2395840 (BAY2395840)

Snippet

Sponsor: Bayer | Conditions: Neuropathic Pain Associated With Diabetic Peripheral Neuropathy, Peripheral Neuropathic Pain | Phase 2 | Status: COMPLETED